MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
Abstract
Rationale 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) increases sociability. The prosocial effects of MDMA may result from the release of the "social hormone" oxytocin and associated alterations in the processing of socioemotional stimuli.Materials and methods We investigated the effects of MDMA (125 mg) on the ability to infer the mental states of others from social cues of the eye region in the Reading the Mind in the Eyes Test. The study included 48 healthy volunteers (24 men, 24 women) and used a double-blind, placebo-controlled, within-subjects design. A choice reaction time test was used to exclude impairments in psychomotor function. We also measured circulating oxytocin and cortisol levels and subjective drug effects.Results MDMA differentially affected mind reading depending on the emotional valence of the stimuli. MDMA enhanced the accuracy of mental state decoding for positive stimuli (e.g., friendly), impaired mind reading for negative stimuli (e.g., hostile), and had no effect on mind reading for neutral stimuli (e.g., reflective). MDMA did not affect psychomotor performance, increased circulating oxytocin and cortisol levels, and produced subjective prosocial effects, including feelings of being more open, talkative, and closer to others.Conclusions The shift in the ability to correctly read socioemotional information toward stimuli associated with positive emotional valence, together with the prosocial feelings elicited by MDMA, may enhance social approach behavior and sociability when MDMA is used recreationally and facilitate therapeutic relationships in MDMA-assisted psychotherapeutic settings.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A third study reported that MDMA at 125 mg increased the recognition of positive and decreased the identification of negative emotions.
“However, a third study reported that MDMA (125 mg) increased the recognition of positive and decreased the identification of negative emotions (54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [54]
In one study, MDMA decreased the decoding of negative emotions from the eye region while at the same time increasing this ability for positive stimuli.
“In one study, MDMA decreased the decoding of negative emotions from the eye region, while at the same time increasing this ability for positive stimuli (54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [54]
Neither duloxetine, reboxetine, nor clonidine blocked the observed increases in decoding accuracy for positive and impaired decoding accuracy for negative stimuli on the RMET after MDMA administration.
“A further study showed that neither duloxetine, which inhibits MDMA-induced monoamine transporter-dependent serotonin and norepinephrine release, reboxetine, which inhibits MDMA-induced norepinephrine release, nor clonidine, which inhibits MDMA-induced transporter-independent vesicular release of norepinephrine, blocked the observed increases in decoding accuracy for positive and impaired decoding”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [54]
Duloxetine was most effective in reducing the acute subjective MDMA effects, implicating the serotonin system as a key mechanism of action.
“However, duloxetine was most effective in reducing the acute subjective MDMA effects, implicating the serotonin system as a key mechanism of action (54).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [54]
Cites
(1970) · Cited by 24,983 · see citing works
Baron‐Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00715 · Cited by 4,555 · see citing works
Baron‐Cohen, S., Wheelwright, S. J., Hill, J., Raste, Y., & Plumb, I. (2001) · PubMed · Cited by 4,313 · see citing works
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.3.280 · Cited by 2,298 · see citing works
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · see citing works
Self-citationOxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639 · see citing works
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298 · see citing works
Self-citationThe human amygdala and the emotional evaluation of sensory stimuli
Zald, D. H. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00248-5 · Cited by 1,062 · see citing works
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962 · see citing works
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945 · see citing works
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2000) · Synapse · doi:10.1002/1098-2396(20010101)39:1 · Cited by 934 · see citing works
Oxytocin attenuates amygdala responses to emotional faces regardless of valence
Domes, G., Heinrichs, M., Gläscher, J., Büchel, C., Braus, D. F., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.025 · Cited by 774 · see citing works
Self-citationOxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans
Hurlemann, R., Patin, A., Onur, O. A., Cohen, M. X., Baumgartner, T., Metzler, S., Dziobek, I., Gallinat, J., Wagner, M., Maier, W., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5538-09.2010 · Cited by 771 · see citing works
Wïttchen, H., Wunderlich, U., Gruschwitz, S., & Zaudig, M. (1997) · Max Planck Institute for Plasma Physics · Cited by 769 · see citing works
Brain oxytocin: A key regulator of emotional and social behaviours in both females and males
Neumann, I. D. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01726.x · Cited by 743 · see citing works
Functional magnetic resonance imaging of reward prediction
Knutson, B., & Cooper, J. C. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000173463.24758.f6 · Cited by 736 · see citing works
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674 · see citing works
Effects of intranasal oxytocin on emotional face processing in women
Domes, G., Lischke, A., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., & Herpertz, S. C. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.016 · Cited by 521 · see citing works
Self-citationThe Symptom Check-List-90-R (SCL-90-R): A German validation study
Schmitz, N., Hartkamp, N., Kiuse, J., Franke, G. H., Reister, G., & Tress, W. (2000) · Quality of Life Research · doi:10.1023/a:1008931926181 · Cited by 430 · see citing works
Mas, M., Farré, M., de la Torre, R., Roset, P. N., Segura, J. O., & Camí, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34877-3 · Cited by 362 · see citing works
Gender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360 · see citing works
Self-citationOxytocin enhances the encoding of positive social memories in humans.
Guastella, A. J., Mitchell, P. B., & Mathews, F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.008 · Cited by 352 · see citing works
Oxytocin improves specific recognition of positive facial expressions
Marsh, A. A., Yu, H. H., Pine, D. S., & Blair, R. J. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1780-4 · Cited by 321 · see citing works
Fertuck, E. A., Jekal, A., Song, I., Wyman, B., Morris, M. C., Wilson, S. T., Brodsky, B. S., & Stanley, B. (2009) · Psychological Medicine · doi:10.1017/s003329170900600x · Cited by 297 · see citing works
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase
White, T. L., Justice, A. J. H., & de Wit, H. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00818-3 · Cited by 248 · see citing works
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248 · see citing works
Self-citationBedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247 · see citing works
Enhanced accuracy of mental state decoding in dysphoric college students
Harkness, K., Sabbagh, M., Jacobson, J., Chowdrey, N., & Chen, T. (2005) · Cognition & Emotion · doi:10.1080/02699930541000110 · Cited by 244 · see citing works
Dumont, G. J. H., Sweep, F. C. G. J., van der Steen, R., Hermsen, R., Donders, A. R. T., Touw, D. J., van Gerven, J. M. A., Buitelaar, J. K., & Verkes, R. J. (2009) · Social Neuroscience · doi:10.1080/17470910802649470 · Cited by 238 · see citing works
Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.032 · Cited by 237 · see citing works
Di Simplicio, M., Massey-Chase, R., Cowen, P., & Harmer, C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108095705 · Cited by 229 · see citing works
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Harris, D. S., Baggott, M., Mendelson, J. H., Mendelson, J. E., & Jones, R. T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1131-1 · Cited by 229 · see citing works
Effects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206 · see citing works
Das Freiburger-Persönlichkeitsinventar (FPI)
Stieglitz, R. (2002) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026//1616-3443.31.3.223 · Cited by 194 · see citing works
Oxytocin increases recognition of masked emotional faces
Schulze, L., Lischke, A., Greif, J., Herpertz, S. C., Heinrichs, M., & Domes, G. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.03.011 · Cited by 180 · see citing works
Self-citationSmeets, T., Dziobek, I., & Wolf, O. T. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.01.011 · Cited by 176 · see citing works
Hysek, C. M., Simmler, L. D., Ineichen, M., Grouzmann, E., Hoener, M. C., Brenneisen, R., Huwyler, J., & Liechti, M. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.78 · Cited by 152 · see citing works
Self-citationLiechti, M. E., & Vollenweider, F. X. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400313 · Cited by 144 · see citing works
Self-citationInterleukin‐1β Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the Rat
Landgraf, R., Neumann, I. D., Holsboer, F., & Pittman, Q. J. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00663.x · Cited by 136 · see citing works
Farré, M., Abanades, S., Roset, P. N., Peiró, A. M., Torrens, M., O'Mathúna, B., Segura, M., & de la Torre, R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.129056 · Cited by 113 · see citing works
Tancer, M., & Johanson, C.-E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0576-z · Cited by 113 · see citing works
Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., & Aitchison, K. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061514 · Cited by 108 · see citing works
How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
Johansen, P., & Krebs, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102787 · Cited by 96 · see citing works
Roelands, B., Goekint, M., Heyman, E., Piacentini, M. F., Watson, P., Hasegawa, H., Buyse, L., Pauwels, F., Schutter, G. D., & MEEUSEN, R. R. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90509.2008 · Cited by 95 · see citing works
Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects
Simmler, L. D., Hysek, C. M., & Liechti, M. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1143 · Cited by 89 · see citing works
Self-citationForsling, M. L., Fallon, J. K., Shah, D., Tilbrook, G. S., Cowan, D., Kicman, A. T., & Hutt, A. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704502 · Cited by 76 · see citing works
Hysek, C. M., Brugger, R., Simmler, L. D., Bruggisser, M., Donzelli, M., Grouzmann, E., Hoener, M. C., & Liechti, M. E. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188425 · Cited by 69 · see citing works
Self-citationPharmacokinetics and pharmacodynamics of nasally delivered midazolam
Haschke, M., Suter, K., Hofmann, S., Witschi, R., Froehlich, J. M., Imanidis, G., Drewe, J., Briellmann, T., Dussy, F. E., Krähenbühl, S., et al. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03611.x · Cited by 56 · see citing works
Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects
Anavekar, S. N., Jarrott, B., Toscano, M., & Louis, W. J. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf01061368 · Cited by 53 · see citing works
Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats
Thompson, M. R., Hunt, G. E., & McGregor, I. S. (2008) · Social Neuroscience · doi:10.1080/17470910802045042 · Cited by 48 · see citing works
Cognitive and psychomotor function in hypoglycemia: response error patterns and retest reliability
Schächinger, H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00167-9 · Cited by 42 · see citing works
Broadbear, J. H., Tunstall, B. J., & Beringer, K. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00267.x · Cited by 38 · see citing works
Effects of the noradrenergic agonist clonidine on temporal and spatial attention
Nieuwenhuis, S., van Nieuwpoort, I. C., Veltman, D. J., & Drent, M. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0770-7 · Cited by 34 · see citing works
Simmler, L. D., Hysek, C. M., Huwyler, J., & Liechti, M. E. (2011) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(11)70408-4 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 409 · see citing works
Self-citationMithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar‐Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376 · see citing works
MDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356 · see citing works
Self-citationDanforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5010-9 · Cited by 280 · see citing works
“MDMA also promotes release of the neurohormone oxytocin (OT) (Dumont et al. 2009; Hysek et al. 2012; Kirkpatrick et al. 2014; Kuypers et al. 2017).”
BackgroundLSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247 · see citing works
Self-citationBaron-Cohen, S., Bowen, D. C., Holt, R. J., Allison, C., Auyeung, B., Lombardo, M. V., Smith, P., & Lai, M.-C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136521 · Cited by 238 · see citing works
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201 · see citing works
Liechti, M. E. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14043 · Cited by 201 · see citing works
Self-citationCarhart-Harris, R. L., Murphy, K., Leech, R., Erritzøe, D., Wall, M. B., Ferguson, B., Williams, L. T. J., Roseman, L., Brugger, S. P., Meer, I. D., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.015 · Cited by 178 · see citing works
Feduccia, A. A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00650 · Cited by 172 · see citing works
Kamilar-Britt, P., & Bedi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.016 · Cited by 163 · see citing works
Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711712 · Cited by 160 · see citing works
Legal highs: staying on top of the flood of novel psychoactive substances
Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314559539 · Cited by 160 · see citing works
Differential effects of MDMA and methylphenidate on social cognition
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114542454 · Cited by 155 · see citing works
Self-citationSafety pharmacology of acute MDMA administration in healthy subjects
Vizeli, P., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691569 · Cited by 149 · see citing works
Self-citationEffects of MDMA and intranasal oxytocin on social and emotional processing
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S., & de Wit, H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.12 · Cited by 143 · see citing works
A meta-analytic review of the correlation between peripheral oxytocin and cortisol concentrations
Brown, C. A., Cardoso, C., & Ellenbogen, M. A. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.11.001 · Cited by 129 · see citing works
Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects
Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K., Kratschmar, D. V., Odermatt, A., & Liechti, M. E. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12374 · Cited by 129 · see citing works
Self-citationHysek, C. M., Simmler, L. D., Schillinger, N., Meyer, N., Schmid, Y., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001132 · Cited by 126 · see citing works
Self-citationWhen is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics
Earp, B. D., Sandberg, A., Kahane, G., & Savulescu, J. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00012 · Cited by 120 · see citing works
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117 · see citing works
Self-citationMDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Danforth, A. L., Struble, C. M., Yazar‐Klosinski, B., & Grob, C. S. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.011 · Cited by 110 · see citing works
Carhart-Harris, R. L., Wall, M. B., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T. M., Bolstridge, M., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001405 · Cited by 108 · see citing works
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., & Jacob, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.006 · Cited by 106 · see citing works
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116663120 · Cited by 106 · see citing works
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Dunlap, L. E., Andrews, A. M., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00155 · Cited by 106 · see citing works
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
Simmler, L. D., Rickli, A., Schramm, Y., Hoener, M. C., & Liechti, M. E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.024 · Cited by 104 · see citing works
Self-citationA brief history of oxytocin and its role in modulating psychostimulant effects
Carson, D. S., Guastella, A. J., Taylor, E. R., & McGregor, I. S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112473788 · Cited by 105 · see citing works
Sessa, B. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.004 · Cited by 97 · see citing works
MDMA alters emotional processing and facilitates positive social interaction
Wardle, M. C., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3570-x · Cited by 96 · see citing works
“Previous research has shown that MDMA reduces perception of negative emotional expressions (Bedi et al. 2010; Hysek et al. 2012; Hysek et al. 2013; Hysek et al. 2014; Kirkpatrick et al. in press), and reduces amygdala responses to angry facial expressions (Bedi et al. 2009).”
InfluentialEmotional Empathy and Psychopathy in Offenders: An Experimental Study
Domes, G., Hollerbach, P., Vohs, K., Mokros, A., & Habermeyer, E. (2013) · Journal of Personality Disorders · doi:10.1521/pedi.2013.27.1.67 · Cited by 96 · see citing works
Self-citationThe 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Sessa, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4713-7 · Cited by 92 · see citing works
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06083-y · Cited by 88 · see citing works
Kuypers, K. P., Dolder, P. C., Ramaekers, J. G., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699617 · Cited by 89 · see citing works
“Blood plasma samples were frozen at −20°C until analysis; MDMA concentrations were determined according to Hysek et al. (2012b) and Pizarro et al. (2002) for the Basel and Maastricht site, respectively.”
BackgroundMethodInfluentialSelf-citationKuypers, K. P. C., de la Torre, R., Farre, M., Yubero-Lahoz, S., Dziobek, I., Van den Bos, W., & Ramaekers, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100719 · Cited by 88 · see citing works
MDMA decreases the effects of simulated social rejection
Frye, C. G., Wardle, M. C., Norman, G. J., & de Wit, H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.030 · Cited by 85 · see citing works
Prosocial effects of MDMA: A measure of generosity
Kirkpatrick, M. G., Delton, A. W., Robertson, T. E., & de Wit, H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573806 · Cited by 85 · see citing works
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works
Psilocybin and MDMA for the treatment of trauma-related psychopathology
Bird, C., Modlin, N. L., & Rucker, J. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1919062 · Cited by 84 · see citing works
Baggott, M. J., Coyle, J. R., Siegrist, J. D., Garrison, K. J., Galloway, G. P., & Mendelson, J. E. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115626348 · Cited by 79 · see citing works
Progress and promise for the MDMA drug development program
Feduccia, A. A., Holland, J. A., & Mithoefer, M. C. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4779-2 · Cited by 78 · see citing works
Feeser, M., Fan, Y., Weigand, A., Hahn, A., Gärtner, M., Böker, H., Grimm, S., & Bajbouj, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.12.015 · Cited by 74 · see citing works
Dipasquale, O., Selvaggi, P., Veronese, M., Gabay, A. S., Turkheimer, F., & Mehta, M. A. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.04.007 · Cited by 68 · see citing works
Effects of MDMA on attention to positive social cues and pleasantness of affective touch
Bershad, A. K., Mayo, L. M., Hedger, K. V., McGlone, F. P., Walker, S. C., & de Wit, H. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0402-z · Cited by 73 · see citing works
Modulation of Social Cognition via Hallucinogens and “Entactogens”
Preller, K. H., & Vollenweider, F. X. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00881 · Cited by 71 · see citing works
Zamberlan, F., Sanz, C., Martínez Vivot, R., Pallavicini, C., Erowid, F., Erowid, E., & Tagliazucchi, E. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00054 · Cited by 71 · see citing works
Positive psychology in the investigation of psychedelics and entactogens: a critical review
Jungaberle, H., Thal, S., Zeuch, A., Rougemont-Bücking, A., von Heyden, M., Aicher, H., & Scheidegger, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.034 · Cited by 70 · see citing works
Pharmacological Challenge Studies with Acute Psychosocial Stress
van Hedger, K., Bershad, A., & de Wit, H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.08.020 · Cited by 67 · see citing works
Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review
de Kleine, R. A., ROTHBAUM, B. O., & van Minnen, A. (2013) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v4i0.21626 · Cited by 67 · see citing works
Intimate insight: MDMA changes how people talk about significant others
Baggott, M. J., Kirkpatrick, M. G., Bedi, G., & de Wit, H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581962 · Cited by 65 · see citing works
Atila, C., Holze, F., Murugesu, R., Rommers, N., Hutter, N., Varghese, N., Sailer, C. O., Eckert, A., Heinrichs, M., Liechti, M. E., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00120-1 · Cited by 64 · see citing works
Self-citationCurrent Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
Thal, S. B., & Lommen, M. J. J. (2018) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-017-9379-2 · Cited by 59 · see citing works
Hysek, C. M., & Liechti, M. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2761-6 · Cited by 58 · see citing works
Self-citationHysek, C. M., Fink, A. E., Simmler, L. D., Donzelli, M., Grouzmann, E., & Liechti, M. E. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182979d32 · Cited by 56 · see citing works
Self-citationEffects of MDMA-assisted therapy for PTSD on self-experience
van der Kolk, B. A., Wang, J. B., Yehuda, R., Bedrosian, L., Coker, A. R., Harrison, C., Mithoefer, M., Yazar-Klosinki, B., Emerson, A., & Doblin, R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295926 · Cited by 55 · see citing works
“…have been shown to improve treatment results for a variety of psychological interventions [33, 34], which invites an exploration of the potential for MDMA in the treatment of PTSD. MDMA may differentially alter emotion recognition, depending on the emotional valence of the stimuli [35].”
BackgroundNaltrexone alters the processing of social and emotional stimuli in healthy adults
Wardle, M. C., Bershad, A. K., & de Wit, H. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1136355 · Cited by 52 · see citing works
Seibert, J., Hysek, C. M., Penno, C. A., Schmid, Y., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2014) · Neuroendocrinology · doi:10.1159/000364879 · Cited by 52 · see citing works
Self-citationWardle, M. C., Kirkpatrick, M. G., & de Wit, H. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsu035 · Cited by 52 · see citing works
Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects
Schmid, Y., Rickli, A., Schaffner, A., Duthaler, U., Grouzmann, E., Hysek, C. M., & Liechti, M. E. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222356 · Cited by 51 · see citing works
Self-citationAmphetamine as a social drug: effects of d-amphetamine on social processing and behavior
Wardle, M. C., Garner, M. J., Munafo, M. R., & de Wit, H. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2708-y · Cited by 50 · see citing works
Lischke, A., Lemke, D., Neubert, J., Hamm, A. O., & Lotze, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-11290-1 · Cited by 48 · see citing works
Oral Contraceptives Impair Complex Emotion Recognition in Healthy Women
Pahnke, R., Mau‐Moeller, A., Junge, M., Wendt, J., Weymar, M., Hamm, A. O., & Lischke, A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01041 · Cited by 46 · see citing works
Vizeli, P., Straumann, I., Duthaler, U., Varghese, N., Eckert, A., Paulus, M. P., Risbrough, V. B., & Liechti, M. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906639 · Cited by 47 · see citing works
Self-citationUrinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration
Francis, S. M., Kirkpatrick, M. G., de Wit, H., & Jacob, S. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.011 · Cited by 46 · see citing works
Stauffer, C. S., Brown, M. R., Adams, D., Cassity, M., & Sevelius, J. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.932605 · Cited by 43 · see citing works
MDMA: a social drug in a social context
Kirkpatrick, M. G., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3752-6 · Cited by 42 · see citing works
Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
González, D., Torrens, M., & Farré, M. (2015) · BioMed Research International · doi:10.1155/2015/643878 · Cited by 43 · see citing works
Humble, M. B., Uvnäs‐Moberg, K., Engström, I., & Bejerot, S. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-344 · Cited by 42 · see citing works
Oeri, H. E. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120920420 · Cited by 41 · see citing works
Feduccia, A. A., Jerome, L., Mithoefer, M. C., & Holland, J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05710-w · Cited by 40 · see citing works
“MDMA enhances release of both oxytocin and ACTH (Dumont et al. 2009; Grob et al. 1996; Hysek et al. 2012).”
BackgroundRetractedEffects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships
Schmid, Y., Hysek, C. M., Preller, K. H., Bosch, O. G., Bilderbeck, A. C., Rogers, R. D., Quednow, B. B., & Liechti, M. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.020 · Cited by 39 · see citing works
Self-citationBorissova, A., Ferguson, B., Wall, M. B., Morgan, C. J. A., Carhart-Harris, R. L., Bolstridge, M., Bloomfield, M., Williams, T. M., Feilding, A., Murphy, K., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120926673 · Cited by 38 · see citing works
Can MDMA Play a Role in the Treatment of Substance Abuse?
Jerome, L., Schuster, S., & Yazar‐Klosinski, B. (2013) · Current Drug Abuse Reviews · doi:10.2174/18744737112059990005 · Cited by 37 · see citing works
Vizeli, P., & Liechti, M. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199384 · Cited by 36 · see citing works
Self-citationDolder, P. C., Strajhar, P., Vizeli, P., Odermatt, A., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4849-0 · Cited by 34 · see citing works
Self-citationOxytocin receptor gene variation predicts subjective responses to MDMA
Bershad, A. K., Weafer, J. J., Kirkpatrick, M. G., Wardle, M. C., Miller, M. A., & de Wit, H. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1143026 · Cited by 34 · see citing works
Carson, D. S., Bosanquet, D., Carter, C. S., Pournajafi‐Nazarloo, H., Blaszczynski, A. P., & McGregor, I. S. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029976 · Cited by 34 · see citing works
MDMA for the Treatment of Negative Symptoms in Schizophrenia
Arnovitz, M. D., Spitzberg, A. J., Davani, A. J., Vadhan, N. P., Holland, J. A., Kane, J. M., & Michaels, T. I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123255 · Cited by 31 · see citing works
Drug effects on responses to emotional facial expressions
Miller, M. A., Bershad, A. K., & de Wit, H. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000164 · Cited by 31 · see citing works
Patin, A., & Hurlemann, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_10 · Cited by 32 · see citing works
Oxytocinergic regulation of endogenous as well as drug-induced mood
Broadbear, J. H., Kabel, D., Tracy, L. M., & Mak, P. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.002 · Cited by 30 · see citing works
Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells
Simmler, L. D., & Liechti, M. E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_20 · Cited by 29 · see citing works
Self-citationQuednow, B. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00005-8 · Cited by 28 · see citing works
Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Egloff, L., Liechti, M. E., & Borgwardt, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx112 · Cited by 25 · see citing works
Self-citationNew psychoactive substances—Synthetic stimulants
Varı̀, M. R., Pichini, S., Giorgetti, R., & Busardò, F. P. (2018) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1197 · Cited by 25 · see citing works
Effects of Acute Doses of Prosocial Drugs Methamphetamine and Alcohol on Plasma Oxytocin Levels
Bershad, A. K., Kirkpatrick, M. G., Seiden, J. A., & de Wit, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000314 · Cited by 24 · see citing works
Feduccia, A. A., Jerome, L., Yazar‐Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021013 · Cited by 24 · see citing works
Wunderli, M. D., Vonmoos, M., Treichler, L., Zeller, C., Dziobek, I., Kræmer, T., Baumgartner, M. R., Seifritz, E., & Quednow, B. B. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx098 · Cited by 22 · see citing works
Straumann, I., Avedisian, I., Klaiber, A., Varghese, N., Eckert, A., Rudin, D., Luethi, D., & Liechti, M. E. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01972-6 · Cited by 21 · see citing works
Self-citationCarlyle, M., Stevens, T., Fawaz, L., Marsh, B., Kosmider, S., & Morgan, C. J. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119826594 · Cited by 21 · see citing works
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez‐Mañá, C., Muga, R., & Farré, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1424832 · Cited by 20 · see citing works
Sarmanlu, M., Kuypers, K. P. C., Vizeli, P., & Kvamme, T. L. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110843 · Cited by 19 · see citing works
Frøkjær, V. G., Erritzøe, D., Holst, K. K., Madsen, K. S., Fisher, P. M., Madsen, J., Svarer, C., & Knudsen, G. M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000066 · Cited by 19 · see citing works
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258849 · Cited by 19 · see citing works
Deng, F., Bueber, M. A., Cao, Y., Tang, J., Bai, X., Cho, Y. I., Lee, J., Lin, Z., Yang, Q., Keshavan, M. S., et al. (2024) · Psychological Medicine · doi:10.1017/s0033291723003501 · Cited by 19 · see citing works
Humble, M. B., & Bejerot, S. (2016) · Sexual Medicine · doi:10.1016/j.esxm.2016.04.002 · Cited by 17 · see citing works
Trust and mindreading in adolescents: the moderating role of social value orientation
Derks, J., van Scheppingen, M. A., Lee, N. C., & A, L. K. M. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00965 · Cited by 17 · see citing works
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17 · see citing works
Self-citationMDMA for the treatment of mood disorder: all talk no substance?
Patel, R., & Titheradge, D. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315583786 · Cited by 16 · see citing works
- Authors
- Hysek, C. M., Domes, G., & Liechti, M. E.
- Affiliations
- University of Basel (CH)
- University of Freiburg (DE)
- Corresponding author
- Liechti, Matthias E.
- Venue
- Psychopharmacology
- Published
- 2012-01-27
- Volume
- 222
- Issue
- 2
- Pages
- 293-302
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2000881947
- Cited by
- 144
- References
- 54
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 13 · 2017: 15 · 2016: 16 · 2015: 17 · 2014: 15 · 2013: 12 · 2012: 4
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- MDMA, ecstasy, theory of mind, emotion recognition, positive emotions, negative emotions, emotional valence, oxytocin, cortisol, prosocial behavior, sociability, Reading the Mind in the Eyes Test, MDMA-assisted psychotherapy
- MeSH terms
- Adolescent, Adult, Double-Blind Method, Emotions, Empathy, Eye, Facial Expression, Female, Hallucinogens, Humans, Hydrocortisone, Male, Oxytocin, Prospective Studies, Psychomotor Performance, Reaction Time, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review